Beta Bionics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Beta Bionics and other ETFs, options, and stocks.

About BBNX

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. 

CEO
Sean Thomas Saint
CEOSean Thomas Saint
Employees
423
Employees423
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2015
Founded2015
Employees
423
Employees423

BBNX Key Statistics

Market cap
526.27M
Market cap526.27M
Price-Earnings ratio
-7.82
Price-Earnings ratio-7.82
Dividend yield
Dividend yield
Average volume
765.18K
Average volume765.18K
High today
$12.41
High today$12.41
Low today
$10.85
Low today$10.85
Open price
$11.27
Open price$11.27
Volume
1.12M
Volume1.12M
52 Week high
$32.71
52 Week high$32.71
52 Week low
$8.80
52 Week low$8.80

Stock Snapshot

As of today, Beta Bionics(BBNX) shares are valued at $11.82. The company's market cap stands at 526.27M, with a P/E ratio of -7.82.

On 2026-05-23, Beta Bionics(BBNX) stock traded between a low of $10.85 and a high of $12.41. Shares are currently priced at $11.82, which is +8.9% above the low and -4.8% below the high.

The Beta Bionics(BBNX)'s current trading volume is 1.12M, compared to an average daily volume of 765.18K.

In the last year, Beta Bionics(BBNX) shares hit a 52-week high of $32.71 and a 52-week low of $8.80.

In the last year, Beta Bionics(BBNX) shares hit a 52-week high of $32.71 and a 52-week low of $8.80.

BBNX News

TipRanks 1d
Beta Bionics Stockholders Approve Directors and Auditor Ratification

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

TipRanks 2d
Beta Bionics price target raised to $13 from $11 at BofA

BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $13 from $11 and keeps a Neutral rating on the shares. Beta Bionics says FDA...

TipRanks 2d
Beta Bionics Targets 2027 Commercial Launch of Mint Pump

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

People also own

Based on the portfolios of people who own BBNX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.